Statement from National HBPA President Dr. Doug Daniels on HISA maintaining status quo on race-day Lasix use

From The National HBPA President Dr. Doug Daniels:

We appreciate the thoughtful and measured decision by the Horseracing Integrity and Safety Authority to reconsider the role of Lasix in race-day care. As the Board approached its vote, it was clear that concern among horsemen and women was intensifying, rooted in the practical realities of managing equine health and welfare without a widely accepted therapeutic tool.

Horsemen across the country are encouraged that the Authority acknowledged both the science and the lived experience of horsemen in concluding that furosemide is not supported as a performance-enhancing substance. This outcome reflects the importance of open dialogue and the willingness to listen to those on the ground who are directly responsible for the health and safety of the horse.

Moving forward, we remain committed to working collaboratively to ensure that policy decisions continue to be guided by science, horsemanship, and the best interests of the horse.

Media contact:

Eric J. Hamelback

CEO, The National HBPA

3380 Paris Pike

KY Training Center

Lexington, KY 40511

859-259-0451 Office
About the National HBPA
The National HBPA is a not-for-profit association founded in 1940 and is headquartered in Lexington, Kentucky. It is the world’s largest Thoroughbred horsemen’s organization, representing approximately 30,000 horse owners and trainers throughout the United States and Canada through its 29 affiliates. The responsibilities of the National HBPA have greatly expanded as the racing industry has become more complex. In addition to its original benevolent mission, the National HBPA is the leading force for horsemen on the national stage, advocating for the advancement of the sport through safety and integrity initiatives, promoting racing, and assisting in the development of aftercare programs for retired horses.